Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
716 (USA) · Dr. Ito
consented 2013-10-02
AEs
4
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-25 (study day 24.0); relationship: PROBABLE
mild
assessed
Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-25 (study day 24.0); relationship: PROBABLE
mild
assessed
Mild UPPER RESPIRATORY TRACT INFECTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-17 (study day 16.0); relationship: NONE
mild
assessed
Mild UPPER RESPIRATORY TRACT INFECTION — outcome: RECOVERED/RESOLVED; onset 2013-10-17 (study day 16.0); relationship: NONE
Data queries
No data queries.